Information  X 
Enter a valid email address

Jlen Environ (JLEN)

  Print      Mail a friend

Tuesday 10 September, 2019

Jlen Environ

Update research from QuotedData

RNS Number : 7161L
Jlen Environmental Assets Grp
10 September 2019
 

JLEN Environmental Assets - Update research from QuotedData

10th Sep 2019

 

Battery storage potential

 

JLEN Environmental Assets (JLEN) recently added two new revenue streams, hydropower and battery storage, to its already-diverse portfolio. It's clear from the 16.5% premium to NAV, that investors are drawn to JLEN and its asset mix. In an environment where interest rates are falling, JLEN's dividend yield (which is well-covered by cash flow) and the relative predictability of its earnings are attractive. Premiums in the sector may look high, but the advisers highlight the conservative nature of JLEN's NAV.

 

Full research:

https://quoteddata.com/research/jlen-environmental-assets-battery-storage-potential2/

 

This research is also available free on our website www.quoteddata.com where you will also find news, performance data and factsheets on every London listed Investment Company. QuotedData writes and distributes research on a number of quoted companies, facilitates meetings between those companies and existing and potential investors and assists in raising additional capital where required.

NB: Marten & Co was paid to produce this note on JLEN Environmental Assets Group and it is for information purposes only. It is not intended to encourage the reader to deal in the security or securities mentioned in this report. Please read the important information at the back of this note. QuotedData is a trading name of Marten & Co Limited which is authorised and regulated by the FCA. Marten & Co is not permitted to provide investment advice to individual investors categorised as Retail Clients under the rules of the Financial Conduct Authority.

QUOTEDDATA
123a Kings Road | London SW3 4PL
Tel: +44 (0) 20 3691 9430

www.quoteddata.com ta.com y to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

 
END
 
 
NRALLFFEARIAIIA

a d v e r t i s e m e n t